Civitas Therapeutics' Series B Round

Civitas Therapeutics raised a round of funding on September 11, 2013.

Civitas is a privately-held biopharmaceutical company focused on developing a pipeline of inhaled therapeutics with the clinically proven ARCUS dry powder pulmonary delivery platform. In addition to t…

Articles about Civitas Therapeutics' Series B Round: